TRV GP Iii, LLC, 10% Owner at Global Blood Therapeutics, Inc. (GBT), sold 1,079,688 shares at $26.95 ($27.7M) on 2017-03-02, disclosed to the SEC on 2017-03-06.
Open-market sale of $27.7M GBT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.50 | 1,000,000 | $25.5M | 92.1% |
| 2 | $26.95 | 27,115 | $731K | 2.6% |
| 3 | $26.95 | 27,115 | $731K | 2.6% |
| 4 | $27.69 | 7,279 | $202K | 0.7% |
| 5 | $27.69 | 7,279 | $202K | 0.7% |
| 6 | $28.73 | 10,900 |
| $313K |
| 1.1% |
| Total | $25.63 avg | 1,079,688 | $27.7M | 100% |